Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LGND

Ligand Pharmaceuticals Inc

May 22 • 04:00PM ET

229.33

+7.15 3.22 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: HALO EXEL VKTX ALKS MDGL

| Held by: IJR VTI VB IWM VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	31.09	EPS (ttm)	7.38	Insider Own	2.57%	Shs Outstand	20.03M	Perf Week	7.56%
Market Cap	4.60B	Forward P/E	20.55	EPS next Y	11.16	Insider Trans	-7.76%	Shs Float	19.56M	Perf Month	0.37%
Enterprise Value	4.27B	PEG	1.24	EPS next Q	2.01	Inst Own	104.61%	Short Float	7.44%	Perf Quarter	24.87%
Income	153.56M	P/S	16.74	EPS this Y	11.35%	Inst Trans	1.06%	Short Ratio	6.43	Perf Half Y	11.30%
Sales	274.48M	P/B	4.61	EPS next Y	23.30%	ROA	12.60%	Short Interest	1.46M	Perf YTD	21.29%
Book/sh	49.79	P/C	5.90	EPS next 5Y	16.58%	ROE	17.13%	52W High	247.38 -7.30%	Perf Year	126.41%
Cash/sh	38.89	P/FCF	37.34	EPS past 3/5Y	- -	ROIC	10.60%	52W Low	98.89 131.90%	Perf 3Y	204.39%
Dividend Est.	-	EV/EBITDA	31.45	Sales past 3/5Y	10.96% 7.54%	Gross Margin	83.42%	Volatility	3.79% 4.49%	Perf 5Y	190.14%
Dividend TTM	-	EV/Sales	15.55	EPS Y/Y TTM	210.12%	Oper. Margin	36.88%	ATR (14)	9.51	Perf 10Y	201.18%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	20.95	Sales Y/Y TTM	51.24%	Profit Margin	55.95%	RSI (14)	57.27	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	21.28	EPS Q/Q	69.66%	SMA20	2.80%	Beta	1.21	Target Price	270.67
Payout	0.00%	Debt/Eq	0.45	Sales Q/Q	14.09%	SMA50	6.13%	Rel Volume	1.63	Prev Close	222.18
Employees	47	LT Debt/Eq	0.45	Earnings	May 07 BMO	SMA200	18.56%	Avg Volume	226.40K	Price	229.33
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	368,267	Change	3.22%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)